Doug Schenkel
Stock Analyst at Wolfe Research
(3.67)
# 785
Out of 4,970 analysts
67
Total ratings
56.52%
Success rate
38.83%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $36.35 | -11.97% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $78.12 | -23.20% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $66.36 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $25.63 | +134.10% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $23.04 | +21.53% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $247.54 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $120.58 | - | 1 | Nov 14, 2024 | |
| MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $2.37 | - | 1 | Nov 14, 2024 | |
| DHR Danaher | Upgrades: Outperform | $285 | $199.03 | +43.19% | 2 | Oct 31, 2024 | |
| BRKR Bruker | Downgrades: Peer Perform | n/a | $29.79 | - | 2 | Sep 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $128.48 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $47.04 | +9.48% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $13.57 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $97.68 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $51.41 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $489.49 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.79 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $85.70 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.24 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $13.19 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $61.36 | - | 2 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $166.56 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $299.69 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.41 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $2.40 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.41 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.50 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.01 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $8.45 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $2.42 | +643.80% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $12.39 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $346.47 | -74.02% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.32 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $190.77 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $80.76 | -80.19% | 2 | Sep 28, 2017 |
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $36.35
Upside: -11.97%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $78.12
Upside: -23.20%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $66.36
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $25.63
Upside: +134.10%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $23.04
Upside: +21.53%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $247.54
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $120.58
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $2.37
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $199.03
Upside: +43.19%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $29.79
Upside: -
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $128.48
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $47.04
Upside: +9.48%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $13.57
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $97.68
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $51.41
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $489.49
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.79
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $85.70
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.24
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $13.19
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $61.36
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $166.56
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $299.69
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.41
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $2.40
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.41
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.50
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.01
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $8.45
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $2.42
Upside: +643.80%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $12.39
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $346.47
Upside: -74.02%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $4.32
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $190.77
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $80.76
Upside: -80.19%